Clinical Trial: A Study to Evaluate the Safety and Efficacy of K-321 Eye Drops After Descemetorhexis in Participants With Fuchs Endothelial Corneal Dystrophy (FECD)
Study Status: Completed
Recruit Status: RECRUITING
Condition: Fuchs Endothelial Corneal Dystrophy
Study Type: INTERVENTIONAL
Official Title: A Double-Masked, Randomized, Placebo-Controlled, Parallel-Group, 12-Week Administration With Two-Week Gradual Dose Taper Phase and 38-Week Follow-Up Phase, Phase 3 Study to Investigate the Safety and
Brief Summary:
A study to assess the safety and efficacy of K-321 in participants with FECD after descemetorhexis.
Read more